Mycobacterium simiae as a cause of intra-abdominal disease: a case report.
A case of intra-abdominal disease caused by Mycobacterium simiae in a Nepalese adult female is reported. She was treated successfully with combination chemotherapy, despite multiple drug resistance in vitro.
Heap
B J
BJ
Department of Medicine, British Military Hospital, Hong Kong.
D000005:Abdomen; D000328:Adult; D001202:Ascitic Fluid / Q000382:microbiology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D007612:Kanamycin / Q000627:therapeutic use; D009161:Mycobacterium / Q000472:pathogenicity*; D009164:Mycobacterium Infections / Q000382:microbiology*; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy / Q000382:microbiology*; D009170:Nontuberculous Mycobacteria / Q000302:isolation & purification / Q000472:pathogenicity*; D015242:Ofloxacin / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use
D011718:Pyrazinamide; D007612:Kanamycin; D015242:Ofloxacin; D007538:Isoniazid; D012293:Rifampin